Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Integra Lifesciences Holdings (IART) Shares Outstanding (2016 - 2025)

Integra Lifesciences Holdings' Shares Outstanding history spans 17 years, with the latest figure at $92.3 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 0.74% year-over-year to $92.3 million; the TTM value through Dec 2025 reached $92.3 million, up 0.74%, while the annual FY2025 figure was $92.3 million, 0.74% up from the prior year.
  • Shares Outstanding for Q4 2025 was $92.3 million at Integra Lifesciences Holdings, roughly flat from $92.3 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $92.3 million in Q2 2025 and bottomed at $89.4 million in Q1 2021.
  • The 5-year median for Shares Outstanding is $90.9 million (2023), against an average of $90.9 million.
  • The largest annual shift saw Shares Outstanding rose 0.32% in 2021 before it rose 0.98% in 2022.
  • A 5-year view of Shares Outstanding shows it stood at $89.6 million in 2021, then increased by 0.98% to $90.5 million in 2022, then grew by 0.49% to $90.9 million in 2023, then increased by 0.76% to $91.6 million in 2024, then increased by 0.74% to $92.3 million in 2025.
  • Per Business Quant, the three most recent readings for IART's Shares Outstanding are $92.3 million (Q4 2025), $92.3 million (Q3 2025), and $92.3 million (Q2 2025).